Augmedix, Inc.
NASDAQ:AUGX
2.345 (USD) • At close October 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 13.664 | 13.471 | 12.68 | 11.767 | 10.78 | 9.628 | 8.751 | 7.864 | 7.333 | 6.985 | 6.577 | 5.625 | 5.173 | 4.79 | 4.543 | 4.245 | 3.725 | 3.97 | 3.958 | 3.668 | 3.241 | 3.241 |
| Cost of Revenue
| 7.209 | 7.13 | 6.434 | 5.937 | 5.715 | 5.242 | 4.702 | 4.274 | 4.131 | 3.872 | 3.64 | 3.092 | 2.761 | 2.665 | 2.536 | 2.369 | 2.195 | 2.59 | 2.596 | 2.34 | 2.246 | 2.246 |
| Gross Profit
| 6.455 | 6.341 | 6.246 | 5.83 | 5.065 | 4.386 | 4.049 | 3.59 | 3.202 | 3.113 | 2.937 | 2.533 | 2.412 | 2.125 | 2.007 | 1.877 | 1.53 | 1.38 | 1.362 | 1.328 | 0.995 | 0.995 |
| Gross Profit Ratio
| 0.472 | 0.471 | 0.493 | 0.495 | 0.47 | 0.456 | 0.463 | 0.457 | 0.437 | 0.446 | 0.447 | 0.45 | 0.466 | 0.444 | 0.442 | 0.442 | 0.411 | 0.348 | 0.344 | 0.362 | 0.307 | 0.307 |
| Reseach & Development Expenses
| 4.418 | 3.833 | 2.94 | 2.936 | 2.59 | 2.71 | 2.612 | 2.608 | 2.649 | 2.28 | 1.943 | 1.81 | 1.499 | 1.426 | 1.037 | 1.009 | 0.985 | 1.491 | 1.795 | 1.951 | 1.616 | 1.616 |
| General & Administrative Expenses
| 7.013 | 5.347 | 4.907 | 4.568 | 4.76 | 4.207 | 4.538 | 4.136 | 4.172 | 4.047 | 3.772 | 3.238 | 3.22 | 3.529 | 3.087 | 3.337 | 2.276 | 2.868 | 2.604 | 2.594 | 2.831 | 2.831 |
| Selling & Marketing Expenses
| 3.749 | 3.563 | 2.746 | 2.729 | 2.649 | 2.563 | 2.339 | 2.304 | 2.432 | 2.231 | 2.049 | 2.157 | 1.728 | 1.574 | 1.453 | 0.887 | 0.819 | 1.239 | 0.949 | 1 | 0.817 | 0.817 |
| SG&A
| 10.762 | 8.91 | 7.653 | 7.297 | 7.409 | 6.77 | 6.877 | 6.44 | 6.604 | 6.278 | 5.821 | 5.395 | 4.948 | 5.103 | 4.54 | 4.223 | 3.095 | 4.107 | 3.553 | 3.595 | 3.648 | 3.648 |
| Other Expenses
| 0.59 | -0.064 | 0.094 | -0.004 | -0.099 | -0.145 | -0.159 | -0.032 | -1.396 | -0.491 | -0.624 | 0.221 | 0 | -0.5 | -0.221 | -0.761 | 0.027 | -0.164 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 15.18 | 12.743 | 10.593 | 10.233 | 9.999 | 9.48 | 9.489 | 9.048 | 9.253 | 8.558 | 7.764 | 7.205 | 6.447 | 6.529 | 5.577 | 5.232 | 4.08 | 5.598 | 4.61 | 6.464 | 4.649 | 4.649 |
| Operating Income
| -8.725 | -6.402 | -4.347 | -4.403 | -4.934 | -5.647 | -5.44 | -5.458 | -6.051 | -5.445 | -4.827 | -4.672 | -4.035 | -4.404 | -3.57 | -3.355 | -2.55 | -4.218 | -3.987 | -4.218 | -4.269 | -4.269 |
| Operating Income Ratio
| -0.639 | -0.475 | -0.343 | -0.374 | -0.458 | -0.587 | -0.622 | -0.694 | -0.825 | -0.78 | -0.734 | -0.831 | -0.78 | -0.919 | -0.786 | -0.79 | -0.685 | -1.063 | -1.007 | -1.15 | -1.317 | -1.317 |
| Total Other Income Expenses Net
| 0.361 | -0.177 | -0.167 | 0.08 | -0.048 | -0.112 | -0.048 | -0.032 | -1.396 | -0.491 | -0.624 | 1.813 | -0.602 | -0.5 | -11.995 | -0.761 | -0.409 | -0.52 | 0.308 | -2.397 | 0.167 | 0.167 |
| Income Before Tax
| -8.364 | -6.579 | -4.515 | -4.407 | -5.033 | -5.239 | -5.599 | -5.49 | -7.447 | -5.936 | -5.451 | -2.859 | -4.637 | -4.904 | -3.791 | -4.116 | -2.959 | -4.738 | -3.678 | -6.615 | -4.103 | -4.103 |
| Income Before Tax Ratio
| -0.612 | -0.488 | -0.356 | -0.375 | -0.467 | -0.544 | -0.64 | -0.698 | -1.016 | -0.85 | -0.829 | -0.508 | -0.896 | -1.024 | -0.834 | -0.97 | -0.794 | -1.194 | -0.929 | -1.803 | -1.266 | -1.266 |
| Income Tax Expense
| 0.086 | -0.08 | -0.024 | 0.084 | 0.051 | 0.033 | 0.159 | 0.032 | 1.396 | -0.339 | -0.168 | 0.81 | 0.003 | -0.202 | -0.001 | -0.214 | 0.466 | 0.193 | 0 | 0 | 0 | 0 |
| Net Income
| -8.45 | -6.499 | -4.491 | -4.407 | -5.033 | -5.272 | -5.758 | -5.522 | -8.843 | -5.936 | -5.451 | -2.859 | -4.637 | -4.904 | -3.79 | -4.116 | -2.959 | -4.738 | -3.678 | -6.615 | -4.103 | -4.103 |
| Net Income Ratio
| -0.618 | -0.482 | -0.354 | -0.375 | -0.467 | -0.548 | -0.658 | -0.702 | -1.206 | -0.85 | -0.829 | -0.508 | -0.896 | -1.024 | -0.834 | -0.97 | -0.794 | -1.194 | -0.929 | -1.803 | -1.266 | -1.266 |
| EPS
| -0.16 | -0.12 | -0.092 | -0.097 | -0.12 | -0.14 | -0.15 | -0.15 | -0.24 | -0.16 | -0.16 | -0.11 | -0.17 | -0.18 | -0.15 | -0.15 | -0.11 | -0.18 | -1.86 | -3.35 | -2.08 | -2.08 |
| EPS Diluted
| -0.16 | -0.12 | -0.092 | -0.097 | -0.12 | -0.14 | -0.15 | -0.15 | -0.24 | -0.16 | -0.16 | -0.11 | -0.17 | -0.18 | -0.14 | -0.15 | -0.11 | -0.18 | -1.86 | -3.35 | -2.08 | -2.08 |
| EBITDA
| -7.309 | -5.963 | -4.041 | -3.43 | -4.162 | -4.705 | -5.091 | -5 | -6.051 | -5.231 | -4.659 | -1.992 | -3.867 | -4.202 | -3.349 | -3.141 | -2.306 | -4.164 | -3.726 | -3.984 | -4.042 | -4.042 |
| EBITDA Ratio
| -0.608 | -0.443 | -0.319 | -0.374 | -0.458 | -0.529 | -0.622 | -0.694 | -0.825 | -0.78 | -0.734 | -0.763 | -0.747 | -0.919 | -0.737 | -0.79 | -0.619 | -1.049 | -0.941 | -1.086 | -1.247 | -1.247 |